Camp4 Therapeutics (CAMP) Invested Capital (2024 - 2025)

Camp4 Therapeutics (CAMP) reported Invested Capital of $74000.0 for Q3 2025, down 12.94% sequentially from $85000.0 in Q2 2025.

Camp4 Therapeutics (CAMP) Invested Capital (2024 - 2025) Analysis & Trends

Camp4 Therapeutics (CAMP) has 2 years of Invested Capital data on file, last reported at $74000.0 in Q3 2025.

For the quarter ending Q3 2025, Invested Capital changed N/A year-over-year to $74000.0; the trailing twelve-month figure through Mar 2026 stood at $159000.0 (down 39.31% YoY), and the FY2024 full-year result was $161000.0, changed N/A from the prior year.
Invested Capital slipped to $74000.0 in Q3 2025, from $85000.0 in the prior quarter.
In the past five years, Invested Capital ranged from a high of $161000.0 in Q4 2024 to a low of $74000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Invested Cap. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	110.96 Mn
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	116.14 Mn
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Camp4 Therapeutics	174.35 Mn	174.35 Mn	-	-

Download Data